Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 21, 2020; 26(7): 725-739
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.725
Table 1 Preoperative clinicopathological, liver function, and operative data of the patients
Overall (n = 215)No postoperative liver failure (n = 188)Postoperative liver failure (n = 27)P value
Age, yr (median)6868720.107
SexMen148125230.073
Women67634
Child-Pugh score5180162180.01
627225
7734
8110
Liver tumorHepatocellular carcinoma8775120.030
Colorectal metastases49463
Hilar cholangiocarcinoma24177
Intrahepatic cholangiocarcinoma20164
Metastatic liver tumor (other than colorectal cancer)22211
Other tumors13130
SurgeryPartial resection11210390.041
Sectionectomy23221
Lobectomy (+extended)735815
Three sectionectomy752
Table 2 Preoperative levels of liver function parameters in patients with and without postoperative liver failure in univariate analysis
FactorNo postoperative liver failure
Postoperative liver failure
Univariate analysis
(n = 188)(n = 27)OR (95%CI)P value
Age, yr (median)68720.095
Sex, male/female125/634/230.064
Preoperative biliary drainage1570.005
Child-Pugh score5.16 ± 0.455.48 ± 0.752.505 (1.345-4.665)0.004
Blood platelet (× 104/μL)19.5 ± 7.716.7 ± 6.60.099
Total bilirubin (mg/dL)0.80 ± 0.330.90 ± 0.390.099
PT-INR (INR)1.00 ± 0.121.09 ± 0.1363.56 (2.533-1595.002)0.012
Albumin (g/dL)4.03 ± 0.453.64 ± 0.540.210 (0.091-0.484)< 0.001
Aspartate aminotransferase (IU/L)30.9 ± 23.640.6 ± 24.81.012 (0.999-1.025)0.071
Alanine aminotransferase (IU/L)27.3 ± 20.732.6 ± 24.20.171
Cholinesterase (IU/L)284.2 ± 82.1194.6 ± 69.90.982 (0.975-0.990)< 0.001
Total cholesterol (mg/dL)188.2 ± 39.2165.8 ± 37.10.984 (0.972-0.996)0.011
ICG-R15 (%)10.9 ± 9.0114.8 ± 11.11.034 (0.998-1.071)0.068
Type IV collagen 7S (ng/mL)5.50 ± 1.918.80 ± 3.061.601 (1.340-1.914)< 0.001
Hyaluronic acid (ng/mL)88.5 ± 100.6256.5 ± 216.51.005 (1.001-1.009)0.018
ARFITM (v/s)1.56 ± 0.572.01 ± 0.692.785 (1.431-5.422)0.003
CRP (mg/dL)0.39 ± 1.010.82 ± 1.331.319 (0.995-1.747)0.054
Extent of hepatic resection[26]0.81 ± 0.971.37 ± 1.041.688 (1.114-2.557)0.013
Table 3 Preoperative liver function parameters in patients with and without post-hepatectomy liver failure in multivariate analysis
FactorsMultivariate analysis
OR (95%CI)P value
Sex, male/female2.802 (0.813-9.653)0.0513
ICG-R15 (%)0.998 (0.951-1.047)0.466
Type IV collagen 7S (ng/mL)1.543 (1.258-1.892)< 0.001
ARFITM (v/s)1.525 (0.673-3.457)0.156
Table 4 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve Child-Pugh class A
FactorsUnivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age, yr (mean)0.984 (0.972-0.996)0.0070.837
Sex, male/female0.6880.656
Child-Pugh score0.577 (0.427-0.780)< 0.0010.123
Cholinesterase (IU/L)1.002 (1.001-1.003)0.0010.346
Total cholesterol (mg/dL)1.004 (1.001-1.007)0.0240.932
ICG-R15 (%)0.980 (0.964-0.997)0.0240.756
Type IV collagen 7S (ng/mL)0.837 (0.784-0.894)< 0.0010.779 (0.682-0.890)< 0.001
Hyaluronic acid (ng/mL)0.996 (0.994-0.999)0.0030.179
ARFITM (v/s)0.651 (0.490-0.866)0.0030.625
CRP (mg/dL)0.792 (0.669-0.936)0.0060.142
Extent of hepatic resection[26]0.813 (0.707-0.936)0.0040.64
Table 5 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve serum total bilirubin < 2 mg/dL
FactorsUnivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age, yr (mean)0.2750.53
Sex, male/female0.1270.222
Child-Pugh score0.749 (0.565-0.994)< 0.0010.21
PT-INR (INR)0.195 (0.47-0.803)0.0240.155
Cholinesterase (IU/L)1.002 (1.001-1.004)0.0030.106
ICG-R15 (%)0.165
Type IV collagen 7S (ng/mL)0.905 (0.851-0.926)0.0010.906 (0.851-0.962)0.001
Hyaluronic acid (ng/mL)0.552
ARFITM (v/s)0.056
CRP (mg/dL)0.118
Extent of hepatic resection[26]0.159
Table 6 Cox proportional hazards analysis to identify predictors of postoperative recovery of liver function to achieve serum albumin > 2.8 g/dL
FactorsUnivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age, yr (mean)0.985 (0.973-0.996)0.0080.18
Sex, male/female0.0590.457
Child-Pugh score0.573 (0.424-0.776)< 0.0010.611
Cholinesterase (IU/L)1.002 (1.001-1.003)0.0010.39
ICG-R15 (%)0.979 (0.962-0.996)0.0080.983
Type IV collagen 7S (ng/mL)0.841 (0.787-0.899)< 0.0010.759 (0.659-0.875)< 0.001
Hyaluronic acid (ng/mL)0.996 (0.994-0.999)0.0040.292
ARFITM (v/s)0.723 (0.545-0.959)0.0240.774
CRP (mg/dL)0.808 (0.685-0.953)0.0110.192
Extent of hepatic resection[26]0.830 (0.722-0.955)0.0090.636
Table 7 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who did not have hepatitis viruses in univariate analysis
FactorsNo postoperative liver failure
Postoperative liver failure
Univariate analysis
(n = 136)(n = 22)OR (95%CI)P value
Age, yr (mean)65.370.70.09
Sex, male/female87/494/180.109
Preoperative biliary drainage940.045
Child-Pugh score5.15 ± 0.395.59 ± 0.803.694 (1.766-7.729)0.001
Platelets (× 104/μL)21.1 ± 7.717.1 ± 7.00.991
Total bilirubin (mg/dL)0.79 ± 0.330.91 ± 0.400.111
PT-INR (INR)0.99 ± 0.131.1 ± 0.14123.581 (2.637-5791.435)0.014
Albumin (g/dL)4.03 ± 0.443.57 ± 0.600.157 (0.059-0.414)< 0.001
Aspartate aminotransferase (IU/L)30.8 ± 26.641.5 ± 25.90.121
Alanine aminotransferase (IU/L)28.0 ± 22.933.6 ± 25.50.296
Cholinesterase (IU/L)293.1 ± 85.1192.2 ± 67.90.979 (0.970-0.988)< 0.001
Total cholesterol (mg/dL)192.2 ± 42.2168.4 ± 40.20.985 (0.973-0.998)0.02
ICG-15 clearance rate (%)10.3 ± 9.1115.0 ± 11.81.034 (0.998-1.081)0.064
Type IV collagen 7S (ng/mL)5.36 ± 1.859.15 ± 3.131.731 (1.383-2.167)< 0.001
Hyaluronic acid (ng/mL)78.7 ± 99.2261.9 ± 207.31.005 (1.004-1.011)< 0.001
ARFITM (v/s)1.49 ± 0.531.98 ± 0.672.785 (1.546-7.887)0.003
CRP (mg/dL)0.47 ± 1.141.00 ± 1.420.056
Extent of hepatic resection[26]0.90 ± 1.01.41 ± 1.051.638 (1.037-2.587)0.034
Table 8 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who did not have hepatitis viruses in multivariate analysis
FactorsMultivariate analysis
OR (95%CI)P value
Cholinesterase (IU/L)0.987 (0.977-0.998)0.0083
ICG-R15 (%)0.959 (0.896-1.026)0.11
Type IV collagen 7S (ng/mL)1.423 (1.074-1.886)0.002
Hyaluronic acid (ng/mL)1.004 (1.000-1.008)0.021
ARFITM (v/s)1.144 (0.406-3.220)0.6
Table 9 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients who had jaundice in univariate analysis
FactorsUnivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age, yr (mean)0.740.817
Sex, male/female0.1050.237
Child-Pugh score0.22
Cholinesterase (IU/L)0.979 (0.970-0.988)0.0660.157
Total cholesterol (mg/dL)0.652
ICG-R15 (%)0.371
Type IV collagen 7S (ng/mL)1.540 (1.036-2.288)0.0331.540 (1.036-2.288)0.033
Hyaluronic acid (ng/mL)0.187
ARFI TM (v/s)0.171
CRP (mg/dL)0.533
Extent of hepatic resection[26]0.481
Table 10 Preoperative liver function parameters in post-hepatectomy liver failure and non-post-hepatectomy liver failure patients in univariate and multivariate analyses for 91 patients
FactorsUnivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age, yr (mean)0.0830.065
Sex, male/female0.4620.557
Child-Pugh score0.347
Platelets (× 104/μL)0.509
PT-INR (INR)0.064
Aspartate aminotransferase (IU/L)0.087
Alanine aminotransferase (IU/L)0.468
Cholinesterase (IU/L)0.986 (0.977-0.995)0.0030.348
Total cholesterol (mg/dL)0.128
ICG-R15 (%)0.643
Type IV collagen 7S (ng/mL)1.514 (0.784-0.894)< 0.0012.178 (0.684-0.890)0.005
Hyaluronic acid (ng/mL)1.005 (1.001-1.009)0.0180.674
ARFITM (v/s)0.145
CRP (mg/dL)0.495
METAVIR score0.801
Extent of hepatic resection[26]2.296 (0.707-0.936)0.0090.86